This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (16)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Tricenter Study

Harold Wanebo, MD; Walley J. Temple, MD; Martin B. Popp, MD; Charles E. Douvill, MD; Michael Yablonski

Arch Surg. 1990;125(3):355-359.

Abstract
• Patients with extremity sarcomas were treated with a neoadjuvant therapy protocol that had originated within the Southeastern Cancer Study Group. Major objectives were to determine tolerance of therapy and its effects on tumor control and survival. After undergoing biopsy, patients received intra-arterial infusion with doxorubicin hydrochloride (Adriamycin) (30 mg every 24 hours) for 3 days and were allocated by institution to receive irradiation of 30 or 35 Gy in 10 fractions or 46 Gy in 23 to 25 fractions. Surgery was done within 7 to 10 days or 30 days pending irradiation dose. Postoperative chemotherapy was given to 31 patients. There were 60 patients, 29 women and 31 men with a median age of 48 years, with 53 soft-tissue tumors and 7 malignant bone tumors. Stages (American Joint Committee on Cancer) included stage IB, 2 patients; stages IIA and IIB, 9 patients; stage IIIA, IIIB, or IIIC, 39 patients; and stages IVA or IVB, 10 patients. Limb salvage surgery was done in 57 patients, including radical resection in 23 with large extensive tumors, wide local excision in 30, excision with narrow margins in 7, primary amputation in 3, and delayed amputation in 2 because of wound complications. There was one local recurrence in the 57 patients who had limb salvage surgery. Disease-free and overall survival at 48 months were 47% and 56%, respectively. We conclude that combined therapy for extremity sarcomas in a multicenter setting resulted in excellent local control, good function, and reasonable long-term survival in patients having limb salvage surgery.

(Arch Surg. 1990;125:355-359)

Author Affiliations
From Brown University, Providence, RI (Dr Wanebo and Mr Yablonski); the University of Calgary (Canada) (Dr Temple); and the University of Cincinnati (Ohio) (Drs Popp and Douvill).

Footnotes
Accepted for publication December 2, 1989.

Read before the annual meeting of the Society of Surgical Oncology, San Francisco, Calif, May 21, 1989.

Reprint requests to Brown University, Roger Williams General Hospital, 825 Chalkstone Ave, Providence, RI 02908 (Dr Wanebo).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?